1423TiP CYCLONE 3: A phase III, randomized, double-blind, placebo-controlled study of abemaciclib in combination with abiraterone plus prednisone in men with high-risk metastatic hormone-sensitive prostate cancer (mHSPC)
| Autor: | McKay, R.R., Agarwal, N., Matsubara, N., Piulats Rodriguez, J.M., Smith, M.R., Todenhöfer, T., Zhang, T., Balar, A.V., Schaverien, C., Sherwood, S., Johnston, E., Lithio, A., Nacerddine, K., Sweeney, C.J. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S1195-S1196 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|